C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2004
10/28/2004	WO2004059277A3 Methods of collecting and transporting vaginal discharge for detection of infectious organisms and to facilitate cervical cancer screening
10/28/2004	WO2004057030A3 Methods and compositions relating to drug-induced arrhythmia
10/28/2004	WO2004053454A3 Methods for detecting invasion of a cell
10/28/2004	WO2004050885A3 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
10/28/2004	WO2004046339A3 Caged sensors, regulators and compounds and uses thereof
10/28/2004	WO2004043386A3 Molecules preferentially associated with effector t cells and methods of their use
10/28/2004	WO2004042013A3 Identification of diet-regulated disease-associated genes
10/28/2004	WO2004040016A3 Genetic markers on chromosome 12 associated to bipolar or unipolar disorders
10/28/2004	WO2004035748A3 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells
10/28/2004	WO2004018709A3 Single nucleotide polymorphisms predicting adverse drug reactions and drug efficacy in cardiovascular disease
10/28/2004	WO2004010848A8 Oncogenes useful for the identification of urinary bladder cancer
10/28/2004	WO2004007681A3 Genetic susceptibility genes for asthma and atopy and asthma-related and atopic-related phenotypes
10/28/2004	WO2004000228A3 Methods for preventing and treating microbial infections by modulating transcription factors
10/28/2004	WO2003104262A3 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
10/28/2004	WO2003099229A3 Functional protein expression for rapid cell-free phenotyping
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004	WO2003087771A3 Method for making a molecularly smooth surface
10/28/2004	WO2003087126A3 Heteroclitic analogs and related methods
10/28/2004	WO2003072738A3 Beta chain-associated regulator of apoptosis
10/28/2004	WO2003057850A3 Binding proteins as biosensors
10/28/2004	WO2003042661A3 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
10/28/2004	WO2003042657A3 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
10/28/2004	WO2003041635A3 Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
10/28/2004	WO2003040347A3 Baalc expression as a diagnostic marker for acute leukemia
10/28/2004	WO2003023053A3 Parameterization of absolute rate models for cytochrome p450 metabolism
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2003014704A3 Rapid and specific detection of campylobacter
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004	US20040216175 Screen for detecting and identifying toxic agents which utilizes animal cleavage stage embryos and enhanced transcriptional patterns
10/28/2004	US20040215401 Computerized analysis of forensic DNA evidence
10/28/2004	US20040215134 Optical detector for enzyme activation
10/28/2004	US20040215087 Compositions and methods for the detection of biomarkers associated with cardiovascular disease
10/28/2004	US20040215031 Functionalized silicon compounds and methods for their synthesis and use
10/28/2004	US20040215012 nucleosides; fluorescent in situ hybridization; for production of combinatorial libraries
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214992 Mutation induced optimization of receptor signal to noise ratio
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214902 Small molecule antagonists of BCL-2 family proteins
10/28/2004	US20040214792 Methods of treating inflammation
10/28/2004	US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing
10/28/2004	US20040214757 nuclear proteins which binds, in a sequence specific manner, to regulatory sequences of immunoglobulin light or heavy chain genes; bioassay
10/28/2004	US20040214349 Molecular marker
10/28/2004	US20040214346 Kit comprising immobilized aggrecanase for use in the diagnosis of thromboembolic disorders
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214318 Viral expression vector comprising enhancing regulatory sequences for use as heterologous gene transfer and expression tool; in vitro transcription/translation systems
10/28/2004	US20040214308 Gamma-glutamylcystein-producing yeast and method of screening the same
10/28/2004	US20040214302 Detection of nucleic acids by type-specific hybrid capture method
10/28/2004	US20040214292 Method of producing template DNA and method of producing protein in cell-free protein synthesis system using the same
10/28/2004	US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214276 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides
10/28/2004	US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004	US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004	US20040214260 Apparatus comprised of a single sheet of paperboard that has been printed, perforated die cut, coated, and laminated to tape for use in collection and transfer of fungi samples
10/28/2004	US20040214259 Methods of sampling microbial communities and apparatus therefore
10/28/2004	US20040214258 Covalent tethering of functional groups to proteins
10/28/2004	US20040214256 Fluorescence detection of proteases or peptidases
10/28/2004	US20040214253 Membrane strip biosensor system for point-of-care testing
10/28/2004	US20040214248 Use of semenogelin in the diagnosis, prognosis and treatment of cancer
10/28/2004	US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/28/2004	US20040214234 Method
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214226 Method of screening candidate compounds for susceptibility to biliary excretion by endogenous transport systems
10/28/2004	US20040214225 Immunoglobulin polypeptide for use as diagnostic tool in detecting variable major protein (VMP) of lymes disease; immunodiagnostics and genetic vaccines preventing parasitic infection
10/28/2004	US20040214224 Identifying two or more of a plurality of sequences differing by one or more single-base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences using one or more primary oligonucleotide primer groups and cyclic replication
10/28/2004	US20040214223 Methods and agents for screening for compounds capable of modulating VEGF expression
10/28/2004	US20040214221 Sequencing nucleotide sequences utilizing reverse transcriptase and generating reaction products comprised mainly or exclusively of modified nucleotides; insitu hybridization
10/28/2004	US20040214219 Nucleotide sequences which code for the tal gene
10/28/2004	US20040214217 Chemiluminescent compounds and use thereof
10/28/2004	US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders
10/28/2004	US20040214213 Diagnosing parkinson's disease via presence of mutation in alcohol dehydrogenase gene; restriction fragment length polymorphisms
10/28/2004	US20040214211 Using computer algorithms in determining identity and orientatiion of specific biopolymers; genomics
10/28/2004	US20040214210 Method of cRNA synthesis
10/28/2004	US20040214207 Using methylation profile of cytokine receptor gene to detect tumor, skin, ateriosclerotic, arthritic, restonotic and vision disorders
10/28/2004	US20040214205 Semiconductor comprising DNA constituents for use in genomic analysis; biochips
10/28/2004	US20040214204 Using prostate specific membrane antigen expression to diagnose recurrence of cell proliferative disorders
10/28/2004	US20040214203 Genes related to sensitivity and resistance to chemotherapeutic drug treatment
10/28/2004	US20040214199 comprising protected hydrazino, oxyamino and carbonyl-based groups biochemical immobilization; solid phase synthesis
10/28/2004	US20040214196 Using ligation and amplification to detect preferential sequences nucleic acids; diagnosing infection and cell proliferative disorders
10/28/2004	US20040214195 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2004	US20040214192 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/28/2004	US20040214183 Monitoring gene promoter and suppressor regulation sequences in eukaryotic and prokaryotic cells under various metabolic states of growth and/or differentiation and after exposure to external changes such as treatment with drugs; gene expression patterning
10/28/2004	US20040214181 Knockout reagent surrogate screening assay
10/28/2004	US20040214179 Breast cancer prognostics
10/28/2004	US20040214178 Transgenic cells comprising viral expression for use as part of assay to determine specific antiviral activity of inhibitors in standard dose responses; drug screening and viricides
10/28/2004	US20040214177 Kit comprising rotaxane modified biopolymers, cyclic molecule and probe that detects changes in signal as cycle passes along monomer units of biopolymer; sequence determination via scanning probe microscope
10/28/2004	US20040214176 Using adjustments in fluorescence to identify preferential oligonucleotide cleavage products
10/28/2004	US20040214174 Reactions on a solid surface
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment

1 ... 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 ... 3003